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Couple infertility and sexual dysfunction are two frus-
trating conditions with a high prevalence in the gen-
eral population. Infertility has been recognized as a 
public health issue by the WHO1; however, no reliable 
figures exist regarding its global prevalence2. In 2006, 
the prevalence of couple infertility was estimated to be 
72.4 million globally according to a study evaluating 
25 population surveys that sampled ~170,000 women1. 
However, another study used a larger data set derived 
from 277 demographic and reproductive health surveys 
and reported infertility in 45.5 million couples in 2010 
(REF. 3). Overall, the median prevalence of couple infertil-
ity has been estimated to be 9%, with rates of 3.5–16.7% 
in developed countries and 6.9–9.3% in less developed 
countries1. A large epidemiological survey by the WHO4 
found that a pure or combined male factor contributes 
to infertility in about half of couples. In addition, a 2013 
study evaluating 22,682 interviews of men and women 
aged 15–44 years reported that in the USA, up to 12% of 
men have fertility problems5.
Sexual dysfunction in men is often present in the 
general population, with 20–30% of adult men globally 
reporting at least one sexual disorder6,7 and prevalence 
increasing with increased age7. To date, validated tools 
for the assessment of male sexual dysfunction are avail-
able only for the study of erectile dysfunction and pre-
mature ejaculation. The estimated prevalence of erectile 
dysfunction and premature ejaculation in men of repro-
ductive age ranges from 12% to 19%7–13 and from 8% to 
31%7,12,13, respectively. This observation is noteworthy, 
considering the high frequencies in relatively young 
men. Erectile dysfunction and premature ejaculation 
are common types of male sexual dysfunction, but, 
since 2012, their prevalence in infertile men has only 
been assessed by a few investigators, using heteroge-
neous tools, none of which had been validated for the 
study of premature ejaculation and only a few for erectile 
dysfunction (TABLE 1). Only a few studies14–16 have inves-
tigated erectile dysfunction and premature ejaculation 
in infertile men using validated instruments, reporting 
a higher frequency of erectile dysfunction14–16 and a 
similar14,15 or higher16 prevalence of premature ejacu-
lation in the men who were part of an infertile couple 
than is observed in the general population of men of a 
similar age.
A possible link between male infertility and sexual 
dysfunction is represented by the psychopathological 
disturbances associated with both conditions, such as 
anxiety and depression. Several studies have investigated 
the psychological burden of infertile men17–19, but only 
a few have focused on mood disturbances in infertile 
patients with sexual dysfunction14–16,20,21.
Decreased general health status is associated with 
impaired male sexual22 and reproductive23 health. The 
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Andrology Unit, Department 
of Experimental and Clinical 
Biomedical Sciences, 
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Abstract | Infertility affects up to 12% of all men, and sexual dysfunction occurs frequently in men 
of reproductive age, causing infertility in some instances. In infertile men, hypoactive sexual 
desire and lack of sexual satisfaction are the most prevalent types of sexual dysfunction, ranging 
from 8.9% to 68.7%. Erectile dysfunction and/or premature ejaculation, evaluated with validated 
tools, have a prevalence of one in six infertile men, and orgasmic dysfunction has a prevalence of 
one in ten infertile men. In addition, infertile men can experience a heavy psychological burden. 
Infertility and its associated psychological concerns can underlie sexual dysfunction. 
Furthermore, general health perturbations can lead to male infertility and/or sexual dysfunction. 
Erectile dysfunction and male infertility are considered proxies for general health, the former 
underlying cardiovascular disorders and the latter cancerous and noncancerous conditions. The 
concept that erectile dysfunction in infertile men might be an early marker of poor general health 
is emerging. Finally, medications used for general health problems can cause sperm abnormalities 
and sexual dysfunction. The treatment of some causes of male infertility might improve semen 
quality and reverse infertility-related sexual dysfunction. In infertile men, an investigation of 
sexual, general, and psychological health status is advisable to improve reproductive problems 
and general health.
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concept that male infertility might be an early marker of 
poor general health is emerging15,24–27.
In this Review, we discuss the correlations between 
sexual dysfunction and male infertility, focusing on the 
associations between reproductive, sexual, psychologi-
cal, and general health.
Sexual dysfunction causes infertility
Prevalence in male infertility
Sexual dysfunction is a rare cause of male infertility14,28,29. 
According to the WHO4, which performed the first large 
study on the aetiology of male infertility (n = 7,273), 
sexual dysfunction accounts for 2.3% of instances of 
unsuccessful fatherhood. In 2000, a single-centre study30 
reported sexual dysfunction as a cause of male infertil-
ity in 4.6% of 1,549 men. Subsequently, further studies 
reported different frequencies, ranging from 0.4% in a 
series of 1,391 subfertile couples31 to 5% in a small cohort 
(n = 98) of infertile couples32. The European Association 
of Urology (EAU)33 reports a prevalence of 2.4%, derived 
from a cohort of 12,945 patients34. Finally, a 2017 study 
including 1,737 patients with severe male factor infertil-
ity reported severe sexual dysfunction as a primary cause 
of infertility in 4.4% of men35. In particular, anorgasmia, 
anejaculation, total retrograde ejaculation, and partial 
retrograde ejaculation accounted for 0.5%, 1.2%, 0.5%, 
and 2.2% of the causes of infertility, respectively35. Severe 
sexual dysfunction was found to be the main causative 
factor (71.1%) in patients with dry ejaculate35. Thus, sex-
ual dysfunction could be the cause of male infertility in 
0.4–4.6% of infertile men.
Types of dysfunction causing infertility
The aetiology of male infertility is related to pretestic-
ular, testicular or post-testicular factors by some inves-
tigators28,36, considering the topographical localization 
of the cause. According to this classification28,36, sexual 
dysfunction is categorized as a pretesticular cause of 
male infertility28,36. Other authors34, who used a more 
detailed classification and relied on the International 
Classification of Diseases (ICD)-10 (REF. 37) codes of 
disorders leading to male infertility, classify sexual 
dysfunction in a category named disturbed semen 
deposition. Types of sexual dysfunction resulting in 
male infertility include erectile dysfunction and ejac-
ulatory disorders, such as anejaculation, retrograde 
ejaculation, and severe premature ejaculation, depend-
ing on organic, iatrogenic, relational, and/or psycho-
genic causes (BOX 1). Of note, male fertility can be 
impaired by sexual dysfunction per se, such as in the 
case of psychogenic erectile dysfunction, or, more often, 
infertility can be caused by the negative effect exerted 
on semen parameters by a systemic disease or by the 
medication used to treat such diseases, which can also 
lead to sexual dysfunction.
Erectile dysfunction. Erectile dysfunction leads to 
impaired fertility through natural conception when a 
severe problem is present, such as absent erection or 
insufficient erection for penetration. Erectile dysfunc-
tion can be caused by organic (such as cardiovascular, 
metabolic, neurogenic, and endocrine factors; BOX 1), 
relational (such as conflicts within the family and/or 
within the couple), and/or intrapsychic (such as anxiety, 
depression) perturbations38. In addition, among infertile 
men, erectile dysfunction is an independent risk factor 
for a reduced frequency of sexual intercourse with an 
obvious negative effect on fertility39. Treatment of erec-
tile dysfunction includes lifestyle modifications, oral and 
parenteral drugs, injectable vasodilator agents, vacuum 
erection devices, surgery, or psychosexual therapy, either 
individually or involving both partners of the couple38,40.
Ejaculatory disorders. Ejaculatory disorders affecting 
male fertility are mainly those resulting in aspermia (dry 
ejaculate), which can occur either because of an inability 
to transport semen (anejaculation) or because of an ina-
bility to ejaculate in an antegrade direction (retrograde 
ejaculation)41.
Anejaculation is the inability to ejaculate through any 
form of stimulation42,43. This condition is relatively rare, 
occurring in 0.14% of the general population44, but is an 
important determinant of male infertility42. Anejaculation 
frequently occurs in men with conditions affecting 
the nervous system, including organic and iatrogenic 
causes42,43,45–47 (BOX 1), but it can also be related to medi-
cations (such as psychotropic drugs)42,45 or psychogenic48 
causes (BOX 1). The most common causes of anejacula-
tion are retroperitoneal lymph node dissection (RPLND) 
and spinal cord injury (SCI), which together account for 
almost 90% of instances45. RPLND is mainly performed 
in men with testis malignancy42. As a testicular tumour 
is the most frequent malignancy in males of reproduc-
tive age49, RPLND can widely affect the fertility of young 
men. Ejaculatory function is lost in 1–19% of men after 
a nerve-sparing procedure45,47,50,51, but this figure rises to 
>20% when post-chemotherapy retroperitoneal fibrosis 
makes it difficult to spare nerves45,46. Regarding SCI, only 
9% of men can achieve ejaculation via masturbation or 
sexual intercourse46,52, and ~95% of SCI patients are una-
ble to procreate without medical intervention42,52.
Retrograde ejaculation occurs when the contrac-
tion of the pelvic muscles associated with the orgasmic 
sensation is not followed by semen expulsion43. This 
phenomenon is caused by incomplete closure of the 
internal sphincter of the bladder, leading to retrograde 
(backwards) ejaculation into the bladder43. Diagnosis of 
Key points
• Infertility affects up to 12% of all men, and sexual dysfunction occurs frequently in 
men of reproductive age, causing infertility in some instances
• Infertile men can experience a heavy psychological burden. Infertility and its 
associated psychological concerns can underlie sexual dysfunction
• General health perturbations can lead to male infertility and/or sexual dysfunction. 
Erectile dysfunction and male infertility are considered proxies for general health
• Medications used for general health problems can cause sperm abnormalities and 
sexual dysfunction. The treatment of some causes of male infertility might improve 
semen quality and reverse infertility-related sexual dysfunction
• In infertile men, an investigation of sexual, general, and psychological health status is 
advisable to improve reproductive problems and general health.
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Table 1 | Studies evaluating sexual dysfunctions in infertile men
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59 16 NA 69% NVQ NA NA NA NA
73 514 NA 17.1%, NVQ 13.5%, NVQ 68.7%, NVQ NA NA




57 40 NA NA 75%, NVQ NA NA NA








74 175 NA 15%, NVQ 66%, NVQ 11%, NVQ NA 8%, NVQ
60 405 NA 11%, IIEF-5 NA NA NA NA
98 18 12 NA NA NA • Lower sexual 
satisfaction in 




62 302 NA 28%, IIEF-5 NA NA NA NA
88 200 NA NA NA 45.4%, NVQ • Low sexual 
satisfaction in 52.5% 




65 100 NA 61.6%, IIEF-15-EFD NA NA NA NA
21 73 NA NA 50%, NVQ NA NA NA
97 357 NA NA NA NA • Low sexual 
satisfaction in 




95 188 190 NA NA NA • Male factor infertility 
scores low sexual 
satisfaction; however, 
no sexual satisfaction 




75 300 NA NA 43%, NVQ NA NA NA
91 156 NA 23.7%, IIEF-5 NA 8.9%, IIEF-5 NA NA
14a 244 NA 17.8%, IIEF-15-EFD 15.6%, PEDT NA NA NA
56a 60 52 • 33.2%, IIEF-15




lower EFD score 
than fertile men 
(26.6%: men with 
a recent diagnosis 
of infertility; 6.7%: 
men in infertile 
couples already 
undergoing IUI)
NA Infertile men show 
lower sexual desire 
than fertile men; IIEF-15
Infertile men show 
lower sexual and 
overall satisfaction 
than fertile men 
IIEF-15
Men with a recent 
(<3 months) 
diagnosis of 
infertility show a 
lower orgasmic 
function score 
than fertile men; 
IIEF-15
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retrograde ejaculation is based on the absence of sper-
matozoa in the seminal fluid when they are present in 
urine after masturbation28. Retrograde ejaculation is the 
only ejaculatory disorder that is exclusively organic in 
origin53. Causes of retrograde ejaculation are classified as 
pharmacological, neurogenic and anatomic53, or organic 
and iatrogenic (BOX 1) and include any factor disrupting 
the ejaculatory reflex and inhibiting bladder neck con-
traction53. Apart from iatrogenic causes, diabetes mel-
litus is the main aetiological factor causing retrograde 
ejaculation43. The frequency of this disorder in patients 
with diabetes (both types 1 and 2) ranges from 6% to 
40%43,46. The estimated prevalence of retrograde ejacula-
tion in patients attending fertility clinics43,53 ranges from 
0.3% to 2%.
The severity of the ejaculatory dysfunction 
depends upon the severity of sympathetic autonomic 
neuropathy46. Anejaculation or retrograde ejacula-
tion can also occur in other conditions affecting the 
peripheral nervous system, such as multiple sclero-
sis. In multiple sclerosis, ejaculatory dysfunction 
is estimated to be present in approximately 50% of 
patients42,45,46. One study54 reported that in 128 non-
spinal-cord injured consecutive patients with organic 
anejaculation, 17 had multiple sclerosis. In a prospec-
tive randomized placebo-controlled double-blind 
study, the authors54 found that out of eight subjects 
with multiple sclerosis treated with midodrine, four 
achieved antegrade ejaculation and two achieved ret-
rograde ejaculation (one with a complete form and 
one with a partial form).
The treatment of aspermia varies depending on 
the underlying aetiology and includes medical ther-
apy with sympathomimetics, urinary sperm retrieval, 
bladder neck reconstruction, prostatic massage, penile 
vibratory stimulation, electroejaculation, and sur-
gical sperm retrieval from the testis or epidydimis41. 
Intracytoplasmatic sperm injection (ICSI) is the main 
reliable option for achieving pregnancy for men with 
aspermia28. In subjects with anejaculation, testicular 
sperm extraction (TESE) is frequently used to retrieve 
sperms from the testes to be used for ICSI41. In retro-
grade ejaculation, spermatozoa retrieved from urine 
can also be used for ICSI. In order to optimize sperma-
tozoa motility, the WHO manual (2010)55 recommends 
alkalinizing the urine by ingesting sodium bicarbonate 
and concentrating the retrograde specimen using the 
density-gradient preparation method. This method 
uses centrifugation of seminal plasma over density gra-
dients consisting of colloidal silica coated with silane, 
which separates cells by their density55. Motile sperm 
actively swim through the gradient material to form a 
soft pellet at the bottom of the tube. Sperm prepara-
tion using density-gradient centrifugation results in a 
fraction of highly motile sperms free from debris and 
other cells55.
Premature ejaculation. Severe premature ejaculation, 
including ejaculation during foreplay, before penetration 
(anteportal ejaculation), or as soon as the penis touches 
the vagina, is a barrier to natural conception, because the 
sperm fails to enter the vagina6,48. In these circumstances, 
treatment including drugs for acquired or lifelong pre-
mature ejaculation and/or psychosexual therapy, or 
assisted reproductive technology (ART) when premature 
ejaculation is resistant to therapy, can help in obtaining 
pregnancy.
Male infertility as a cause of sexual dysfunction
The prevalence of sexual dysfunction in infertile men 
ranges between 6.7%56 and 75%57 (TABLE 1). Notably, 
infertility can exert a detrimental effect on sexual, 
psychological, and marital life of both partners in the 
couple17,18, and the presence of a simultaneous female 
disorder can negatively affect the couple’s sexual 
response. In fact, women in infertile couples might 
experience sexual dysfunction, such as hypoactive sex-
ual desire, arousal dysfunction, anorgasmia, dyspareu-
nia, and vaginismus, as well as anxiety, depression, and 
difficulties in marital relationships17,18, which can in turn 
16a 1,498 942 18.05%, IIEF-15-EFD 19.01%, PEDT NA NA NA
63a 1,750 NA 30.5%, IIEF-5 NA NA NA NA




20a 236 NA 50.8%, IIEF-5 NA NA NA NA
15a 488 74 18.3%, IIEF-15-EFD 12.9%, PEDT Men with azoospermia 
men show a lower 
sexual desire score than 
fertile men; IIEF-15
No difference in sexual 
satisfaction comparing 




men have lower 
orgasmic function 
score than fertile 
men; IIEF-15
EFD, erectile function domain; IIEF, International Index of Erectile Function; ISS, Index of Sexual Satisfaction; IUI, intrauterine insemination; NA, not applicable; 
NVQ, not validated questionnaire; PEDT, Premature Ejaculation Diagnostic Tool; SEAR, Self-Esteem and Relationship Questionnaire. aStudies published since 2012.
Table 1 (cont.) | Studies evaluating sexual dysfunctions in infertile men
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trigger or worsen male sexual dysfunction. Thus, infer-
tility-related male sexual dysfunction can be affected by 
confounders, such as the presence of female sexual and 
psychological disorders.
Erectile dysfunction
The prevalence of erectile dysfunction in infertile 
men has been assessed by a few investigators and is 
relatively novel research (TABLE 1). The first reports on 
this issue were from Berger in 1980 (REFS 58,59), who 
observed that 11 men in a small cohort of 16 couples 
experienced impotency after discovering they were 
infertile, using a nonvalidated tool. In 2003, Saleh 
et al.60 reported that 11% of men undergoing infer-
tility evaluation after detection of abnormal results 
in their first semen analysis experienced erectile 
problems when assessed by the validated instrument 
International Index of Erectile Function (IIEF)-5 in a 
larger series (n = 405)61. Using the same tool61, O’Brien 
et al.62 and Satkunasivam et al.63 found frequencies of 
erectile dysfunction in infertile men of 28% (n = 302) 
and 30.5% (n = 1,750), respectively. In a smaller cohort 
(n = 30), Marci et al.56 found that prevalence of erec-
tile dysfunction was 26.6% in 30 men who had been 
recently (within two months) diagnosed with pri-
mary infertility and 6.7% in 30 infertile men who 
were part of a couple who were undergoing intrauter-
ine insemination used the IIEF-15-erectile function 
domain (IIEF-15-EFD)64. Subsequent studies using the 
IIEF-15-EFD reported that prevalence of erectile dys-
function was ~18% in cohorts of 244 (REF. 14) and 448 
(REF. 15) men in infertile couples. A study performed in 
a Chinese population (n = 1,498) also reported an 18% 
prevalence of erectile dysfunction in infertile men16. 
Hence, a prevalence of 11–30.5% has been reported in 
studies investigating a relatively large cohort of men 
with couple infertility15,16,60,62,63. Notably, two other 
studies have been published on this topic, finding a 
higher prevalence of erectile dysfunction in infertile 
men than in those discussed above. Khademi et al.65 
found the frequency of erectile dysfunction to be 
61.6% in 100 infertile men, using the IIEF-15-EFD, 
and Song et al.20 reported a prevalence of 50.8% in 236 
men in infertile couples using the IIEF-5. Khademi 
et  al.65 speculated that the different frequencies 
reported compared with other studies were caused by 
increased rates of mild-to-moderate erectile dysfunc-
tion in their population. Notably, a high percentage of 
infertile men who had mild (32.3%) or mild-to-mod-
erate (22.2%) erectile dysfunction was reported by 
Khademi and colleagues65, whereas 42% of men had a 
mild form of erectile dysfunction in the study by Song 
and co-workers20. The reason why such a high preva-
lence of erectile dysfunction was found in these stud-
ies20,65 is difficult to determine. Possibly, the patients 
evaluated could have been seeking medical care not 
only for infertility but also for sexual dysfunction, 
owing to the high prevalence of erectile dysfunction 
in the populations studied20,56. Hence, considering the 
studies investigating erectile dysfunction in infertile 
men, its prevalence ranges from 6.7%56 to 61.6%65.
Erectile dysfunction increases as a function of sever-
ity of semen quality impairment, being higher in men 
with azoospermia than in men in infertile couples with at 
least one abnormality in conventional sperm parameters 
or with normozoospermia15, and than in fertile men15. 















 - Spinal cord injury
 - Diabetic neuropathy
 - Multiple sclerosis
 - Transverse myelitis
 - Vascular spine injuries
 - Congenital spinal anomalies (such as spina bifida)
 - Hormonal disorders (hyperprolactinaemia, hypogonadism, and hypothyroidism)
• Iatrogenic causes
 - Retroperitoneal lymph node dissection
 - Prostatectomy
 - Rectal surgery
 - Pelvic radiation
 - Drugs (psychotropic drugs and α-blockers)
• Relational causes
• Psychogenic causes (such as fear, anxiety, hostility, relationship difficulties, orthodoxy 
of religious belief, autosexual orientation, and disparity between sex reality and the 
use of sexual fantasy)
Retrograde ejaculation
• Organic causes
 - Spinal cord injury
 - Diabetic neuropathy
 - Multiple sclerosis
 - Myelodysplasia
 - Cerebrovascular accidents
 - Congenital (posterior urethral valves, utricular cysts, and extrophy)
• Iatrogenic causes
 - Lumbar sympathectomy
 - Retroperitoneal lymph node dissection
 - Aortoiliac vascular surgery
 - Abdominoperineal resection
 - Transurethral bladder neck incision and transurethral resection of prostate
 - Drugs (psychotropic drugs)
Premature ejaculation
• Organic causes
 - Male genital tract inflammation
 - Hyperthyroidism (varicocele)
• Iatrogenic causes
 - Psychotropic drugs
• Relational causes
• Psychogenic causes
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All the available studies comparing the erectile function 
of men who are part of an infertile couple and those who 
are members of a fertile couple found a significantly 
increased prevalence of erectile dysfunction in infer-
tile men (P = 0.006 (REF. 15); P < 0.001 (REF. 16); P = 0.007 
(REF. 62); P < 0.0005 (REF. 56)). In addition, the frequency 
of erectile dysfunction in infertile men has been reported 
as higher than that of age-matched and geographically 
matched men in the general population14,16,66. However, 
frequency of erectile dysfunction increases with age 
and its related comorbidities, including hypogonadism; 
thus, the demonstration of an independent association 
between erectile dysfunction and infertility is difficult. 
One study15 reported a significant association between 
erectile dysfunction and semen quality impairment after 
adjusting for age, comorbidities, and psychological and 
prostatitis-like symptoms (P < 0.0001). No differences 
in serum testosterone levels were observed15. In 2017, 
Sahin et al.67 reported an association between erectile 
dysfunction and depressive symptoms independent of 
age, BMI, and duration of marriage in a small but select 
cohort of men without comorbidities with primary 
(n = 39) or secondary (n = 31) infertility. Similar find-
ings were observed in both subgroups of participants, 
but men with secondary infertility were older, had older 
partners, longer marriage duration, higher erectile dys-
function rates, and higher depression rates than men 
with primary erectile dysfunction67. These figures are 
expected in men with secondary infertility, but the main 
implication of this study67 is that erectile dysfunction is 
independently associated with depressive symptoms 
regardless of the type of infertility (primary or second-
ary) in infertile men.
The simultaneous presence of sexual dysfunction in 
the female partner of an infertile couple could contrib-
ute to the deterioration of erectile function17,18. Women 
with secondary infertility had lower scores on the 
Female Sexual Function Index in the orgasm68, satisfac-
tion68, arousal69, and desire70 subdomains than women 
with primary infertility. In addition, it could be specu-
lated that the presence of children could further impair 
a couple’s sexuality in secondary infertility. No specific 
study on this topic has been performed on men with 
secondary infertility; however, studies investigating the 
association of fatherhood and sexual dysfunction have 
been performed in cohorts of men primarily complain-
ing of sexual dysfunction. One study71 reported that 
increasing numbers of children are associated with an 
increasing severity of lack of sexual privacy, and that the 
latter is associated with mild erectile dysfunction, par-
ticularly with regards to intrapsychic and relational, but 
not organic, domains, measured using the scales of the 
Structured Interview on Erectile Dysfunction (SIEDY). 
Another study reported that an increasing number of 
children is associated with a decrease in testosterone 
levels and with a worse metabolic and cardiovascular 
profile, as well as worse penile blood flow in men with 
sexual dysfunction72. Thus, the lack of privacy experi-
enced by couples with secondary infertility could be a 
factor that negatively affects sexual function. Hence, 
similar studies in an infertility setting are advisable.
Ejaculatory disorders
The prevalence of ejaculatory disorders in infertile men 
has been investigated with validated instruments by a few 
researchers15–17. Since 2012, a limited number of studies 
have assessed premature ejaculation in infertile men, 
using unvalidated tools (TABLE 1). One study showed a 
prevalence of premature ejaculation in infertile men of 
13.5%73, but the majority of the authors reported higher 
rates, such as 75%57, 66%74, 50%21, and 43%75, in rela-
tively small cohorts (TABLE 1). These frequencies21,57,74,75 
are similar to those reported by previous studies (75%44 
and 69%76) but higher than those reported by other 
authors (31%8, 15%12, 31%13, and 36%77) in the general 
population. Studies involving more participants than 
the studies published since 2012 that used a validated 
instrument for assessing premature ejaculation (such as 
the Premature Ejaculation Diagnostic Tool78) reported 
a frequency of premature ejaculation in men in infertile 
couples of 15.6%14, 19%16, and 12.9%15. The prevalence of 
premature ejaculation reported in studies in the Italian 
population of infertile men14,15 was similar to that found 
in the general Italian population11 (11.6%), whereas the 
prevalence observed by Gao et al.16 in a Chinese popu-
lation of infertile men was higher than that of a compar-
ative study in the general Chinese population79 (11%).
Hassanzadeh et al.75 found that in 300 infertile Iranian 
men, 129 had premature ejaculation, of whom 74% had 
the lifelong form, and 26% had acquired premature 
ejaculation. These figures are similar to those reported 
by Serefoglu et al.80 in 261 Turkish men admitted to an 
urology outpatient clinic with a self-reported complaint 
of premature ejaculation (62.5% with the lifelong form 
and 16.1% with the acquired form). Conversely, Lotti 
et al.14 reported in an Italian study that in 244 consec-
utive men with couple infertility, 38 had premature 
ejaculation, of whom 38.5% had the lifelong form, and 
61.5% had the acquired form. These frequencies were 
similar to those reported by Basile Fasolo et al.81 in 
2,658 Italian men with premature ejaculation admitted 
to an outpatient clinic for free andrological consultation 
(21.4% with lifelong and 69.8% with acquired prema-
ture ejaculation). In addition, in the general population, 
a considerably higher prevalence of acquired than life-
long premature ejaculation has been reported by studies 
performed in Turkey82 (19.2% and 11.2%, respectively, 
in 520 men with premature ejaculation out of a cohort 
of 2,593 men) and in China83 (18.8% and 12.3%, respec-
tively, detected in 778 men with premature ejaculation 
out of a cohort of 3,016 men). Hence, a disparity exists 
between the frequency of the premature ejaculation sub-
types (lifelong and acquired) in the general community 
and in men actively seeking treatment for premature 
ejaculation84. This result suggests that the majority of 
patients seeking treatment for premature ejaculation 
suffer from the lifelong subtype84, whereas, in other 
settings, the acquired form is more frequent. The study 
by Lotti and colleagues14, conducted in an infertility set-
ting, is in line with this hypothesis84, whereas the results 
from the study by Hassanzadeh and co-workers75, per-
formed in the same setting, give opposite results. This 
discrepancy could be because Hassanzadeh et al.75 used 
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an unvalidated questionnaire to assess premature ejac-
ulation, possibly identifying more men with a lifelong 
form because of a bias related to the diagnostic tool used, 
giving higher rates than those reported by Lotti et al.14 
(43% versus 15.6%). Further studies using validated 
tools are needed to clarify this discrepancy. Patients 
with acquired premature ejaculation, but not those with 
lifelong premature ejaculation, had a significantly higher 
prevalence of prostatitis-like symptoms (25% versus 
1.5%; P < 0.0001) and colour-Doppler ultrasonography 
features of prostatic inflammation than patients with-
out premature ejaculation14. Acquired premature ejacu-
lation can be caused by underlying hyperthyroidism85,86; 
however, only small studies (n = 2–23) focusing on 
overt hyperthyroidism and male fertility have been per-
formed87, and no study has investigated the relationship 
between hyperthyroidism and premature ejaculation in 
infertile men.
A diagnosis of infertility can also lead to psychogenic 
anejaculation19. Psychogenic anejaculation can also be 
observed in men who do not wish to be fathers for psy-
chological or social issues19.
Hypoactive sexual desire disorder
Articles on the association between infertility and sex-
ual dysfunction report hypoactive sexual desire disor-
der (HSDD) as a frequent factor in infertile couples6,17–19, 
but they mainly focus on women’s libido, whereas those 
investigating male sexual desire are lacking. Loss of 
libido in men in an infertile couple has been studied 
by only a few investigators, often without validated 
instruments (TABLE 1). In addition, no tool investigat-
ing libido has a validated cut-off value distinguishing 
normal sexual desire from low sexual desire, so studies 
often detail only self-reported feelings or comparison 
between infertile and control groups (TABLE 1). HSDD 
has been reported to be more prevalent in infertile men, 
with frequencies up to 45.4%88 or 68.7%73, than in the 
general population, in which its prevalence ranges from 
5%8 to 18.1%89. Van Zyl73 reported an impaired sexual 
interest in 68.7% of men in 514 couples complaining of 
infertility without using any validated tool. Jain et al.74 
reported decreased libido in 11% of 175 men in infer-
tile couples using an unvalidated tool. Ramezanzadeh 
et al.88 found that 45.4% of 200 men in infertile couples 
reported a reduction in sexual desire after an infertility 
diagnosis using a self-administered structured ques-
tionnaire with a five-point rating scale assessing sexual 
desire and satisfaction (ranging from 1 = very unsatisfied 
to 5 = very satisfied). However, the authors also reported 
that libido did not show a considerable decrease com-
pared with the recalled sexual desire before diagnosis88. 
A 52% frequency of HSDD in infertile men has been 
reported17,18. Bechoua et al.19 reported that HSDD is the 
most frequent sexual dysfunction in infertile couples; 
however, this observation is limited by the fact that only 
studies published in French and one29 in English were 
assessed in this study. Psychological pressure and loss 
of spontaneity, resulting from sex aimed at conception 
or perceived as mandatory during the ovulatory phase 
of the partner, was the major explanation for HSDD in 
this context17–20,90. Elia et al.91 reported problems with sex 
for pleasure in 8.9% of 156 men in infertile couples and 
that the sexual desire of men having sex for reproduc-
tive purposes was lower than that in men having sex for 
pleasure or control groups, using the IIEF-5. In 2012, a 
study using the IIEF-15 reported that infertile men have 
lower sexual desire than fertile men56. Thus, infertile 
men show high rates of HSDD, with a prevalence rang-
ing from 8.9%91 to 68.7%73, which is derived from studies 
that used unvalidated tools73,74,88 except for one study91.
Of note, results of one study88 showed that sexual 
desire was negatively associated with duration of infertility 
and positively associated with coitus frequency, although 
in a multivariate model including the two factors as covar-
iates, only coital frequency showed an independent asso-
ciation with libido. In addition, no significant difference in 
sexual desire between subjects with a recent (<3 months) 
or long-lasting (3–180 months) infertility diagnosis was 
observed (P = 0.075)88. Similar results were reported 
by others56 using the validated tool IIEF-15 (TABLE 1). 
Duration of marital relationship should have been consid-
ered as a confounder, as a long relationship span is often 
associated with a decrease of sexual desire88. Hence, sex-
ual desire is associated with coital frequency but not with 
duration of infertility, but the effect of duration of marital 
relationship should be considered in further studies.
Finally, the relationship between sexual desire and 
sexual arousal in infertile men is still debated. Some 
reports suggest that sexual arousal is maintained despite 
HSDD in infertile men and during infertility manage-
ment19,92,93. However, other studies report a decrease in 
sexual arousal in infertile men19,56,94. The reduction of 
sexual desire in infertile couples has been related to the 
fact that sexual activity is focused on procreation rather 
than recreation and that the intrusive medical require-
ments affect intimacy19,93, but results for pleasure during 
intercourse are discrepant and need further study.
Satisfaction and relationships
The reported associations between infertility and 
satisfaction (sexual or overall) are mainly based on 
qualitative studies18. In addition, the majority of the 
publications also analyse associations with marital rela-
tionship instability88,95–101. Several studies report that 
sexual satisfaction decreases after a diagnosis of infer-
tility and during ART (see reviews18,19 and TABLE 1). In 
particular, a low sexual satisfaction was reported after 
the infertility diagnosis95–97. Drosdzol and Skrzypulec95 
found that diagnosed male factor infertility and an infer-
tility duration of 3–6 years were connected with the low-
est sexual satisfaction by evaluating 188 infertile men 
using a validated Polish version of the Index of Sexual 
Satisfaction (ISS). Andrews et al.96 found a weak asso-
ciation (R = 0.44) between male fertility-related stress 
and sexual dissatisfaction in 157 infertile couples using 
an unvalidated multiple-item scales questionnaire, but 
the duration of infertility was not reported. Smith et al.97 
found that those with an isolated male infertility factor 
showed the lowest sexual satisfaction among 357 men in 
infertile couples (infertility duration 1.4–2.3 years) using 
an unvalidated five-item sexual impact scale derived 
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from the Fertility Problem Inventory. Monga et al.98 
suggested that perceived male factor infertility leads 
to feelings of inadequacy, decreased self-esteem, and 
increased stress levels, which affect sexual satisfaction. A 
2014 study investigating sexuality, self-esteem, and qual-
ity of the partnership99 in 153 males of infertile couples 
showed that infertility is associated with reduced sexual 
and overall satisfaction in the relationship, self-esteem, 
and confidence, using the Self-Esteem and Relationship 
Questionnaire (SEAR). However, a prospective inves-
tigation reported no considerable changes in sexual 
satisfaction, evaluated using the ISS, and aspects of part-
nership, evaluated using the Relationship Change Scale 
(RCS), after infertility diagnosis100. The discrepancy in 
the results of different studies could be related to the dif-
ferent types of unvalidated and validated tools used to 
investigate this topic. Muller et al.101 and Ramezanzadeh 
et al.88 found that, on average, sexual satisfaction was 
high in infertile males, without a significant difference 
(P = 0.08 and P = 0.082, respectively) from sexual satis-
faction recalled from before diagnosis.
Some studies showed no substantial group differences 
between sexual satisfaction in men in infertile couples 
and men in fertile couples15,95, whereas others reported 
lower satisfaction in infertile men56,101. Importantly, the 
latter studies56,101 evaluated smaller cohorts of infertile 
and fertile couples (TABLE 1); hence, they could have a 
low statistical power. In addition, Elia et al.91 reported 
that the intercourse satisfaction of men having sex for 
reproductive purposes was lower than that of those hav-
ing sex for pleasure or than in control groups, using the 
IIEF-5 (TABLE 1). Thus, the issue of sexual and overall 
satisfaction in infertile men is still debated, and larger 
systematic studies are needed to improve our under-
standing of this topic.
Considering factors potentially related to satisfaction 
in infertile couples, studies have focused on different top-
ics, including duration of infertility, coitus frequency, tim-
ing of infertility diagnosis, cause of infertility, age of the 
male partner, education levels, and mutual understanding 
in marital life. Ramezanzadeh et al.88 reported that dura-
tion of infertility was negatively associated with sexual 
satisfaction, whereas coitus frequency showed a positive 
correlation. However, in a multivariate model including 
the two factors as covariates, only coitus frequency showed 
an independent association with sexual satisfaction. 
Hence, coitus frequency was proposed as an acceptable 
indicator of sexual satisfaction in infertile men88, which 
is in agreement with a previous study101. Marci and col-
leagues56, using the validated IIEF-15, and Ramezanzadeh 
and co-workers88, using an unvalidated tool, found no 
difference in sexual and overall satisfaction between men 
with a recent infertility diagnosis (<3 months) and those 
with a long-lasting (3–180 months) diagnosis of infer-
tility. In addition, Ramezanzadeh et al.88 also reported 
that the age of men in an infertile couple and the cause 
of infertility have no relationship with sexual satisfaction. 
Finally, these investigators found a significant inverse rela-
tionship between education levels or mutual understand-
ing in marital life and sexual satisfaction (both P < 0.05) 
after a diagnosis of infertility88. Lee et al.102 observed 
that husbands had higher sexual satisfaction than their 
wives in couples in which both partners were infer-
tile. However, no differences in sexual satisfaction were 
observed between partners when the cause of infertility 
was unknown102. Men in couples in which the woman is 
infertile experienced lower global and self-esteem distress 
and guilt or blame than their spouses102, whereas men in 
couples in which infertility was male or mixed factor or 
with unexplained infertility showed no differences from 
their female partners102. These results suggest that when 
there is a clear female contribution to the infertility status 
of the couple, both isolated or mixed with a male factor, 
women feel more guilt than men, whereas in all other 
instances, no differences in blame or distress between 
spouses are present.
Regarding the marital relationship in infertile cou-
ples, a systematic review of quantitative studies103 con-
cluded that male factor infertility does not negatively 
affect marriage. However, increased age of the infertile 
spouse, reduced education level, and reduced congru-
ency of couples’ perceptions of infertility were associ-
ated with worse quality of marital relationship103. Of 
note, infertile men had higher marital satisfaction than 
their wives103. These results suggest that women are more 
sensitive and suffer more than men in relation to the 
couple’s infertility status, which negatively affects their 
marital satisfaction.
In conclusion, male factor infertility does not seem to 
affect dyadic relationships, but it might have a negative 
effect on sexual and overall satisfaction.
Orgasmic dysfunction
Orgasmic function in women in infertile couples has 
been widely investigated17,18, but studies involving infer-
tile men are limited and have been rarely performed 
using validated instruments (TABLE  1). Jain et  al.74 
reported male orgasmic failure in 8% of 175 infertile 
men using an unvalidated questionnaire according to 
the ICD-103 (TABLE 1). Saleh et al.60 found that 11% of 
405 men undergoing infertility evaluation experienced 
problems with orgasm using the IIEF-15. In particular, 
these men failed to collect semen for a second analysis 
by masturbation or during sexual intercourse at home 
after detection of abnormalities in one or more standard 
semen parameters in their first semen analysis, reporting 
severe anxiety60. Elia et al.91 reported that the orgasmic 
function of men having sex for reproductive purposes 
was lower than that of those sex for pleasure or control 
groups using the IIEF-5 (TABLE 1). Thus, about one in ten 
infertile men might experience orgasmic dysfunction.
Azoospermia and sexual dysfunction
The discovery of azoospermia can be a devastating 
experience for a couple during infertility evaluation19. 
This news has been described as the worst news ever 
received by infertile men104 and has been associated 
with a deep sense of inadequacy104. However, the pos-
sibility of becoming a father by surgical sperm retrieval 
and intracytoplasmic sperm injection results in feelings 
of redress, enhancing self-esteem104. Some men experi-
ence a period of temporary erectile dysfunction after a 
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diagnosis of azoospermia58,59. A 2016 study15 demon-
strated that men with azoospermia have worse erectile 
function than other men who are part of an infertile or 
fertile couple, with a prevalence of erectile dysfunction 
of ~27%15. In addition, these men had higher frequency 
of premature ejaculation, lower sexual desire, and poorer 
orgasmic function than fertile men15 (TABLE 1).
Azoospermia can be classified as obstructive or non-
obstructive49. To date, only one study105 has evaluated 
the effect of TESE outcome on sexual function in men 
with nonobstructive azoospermia. Unsuccessful TESE 
procedures were reported to have a negative effect on 
erectile function, related to hormonal and psychological 
issues, which was measured using the IIEF-5 (REF. 105). 
However, information on sexual dysfunction in men 
with nonobstructive azoospermia can be extrapo-
lated from studies investigating sexual dysfunction in 
patients with genetic abnormalities that are often asso-
ciated with nonobstructive azoospermia, such as those 
with Klinefelter syndrome, 46,XX testicular disorder of 
sexual development, or congenital hypogonadotropic 
hypogonadism. Raboch et al.106 reported that the aver-
age sexual activity of 110 men with Klinefelter syndrome 
examined for sterility was significantly lower than that 
of 325 normozoospermic and potent men when meas-
ured using the Sexual Activity of Men questionnaire 
(P = 0.001). Yoshida et al.107 found a prevalence of sexual 
dysfunction of 67.5% in 40 men with Klinefelter syn-
drome complaining of infertility (39 with azoospermia 
and 1 with severe oligoasthenospermia). However, men 
with Klinefelter syndrome showed no significant differ-
ence in the frequency of sexual dysfunction compared 
with a control group of 55 infertile nonazoospermic 
men with a normal karyotype107. The mean frequency 
of sexual intercourse per month in the patients with 
Klinefelter syndrome was significantly higher than 
in the control group (P < 0.05), probably because they 
wished to continue to have relations as a couple after 
the diagnosis of azoospermia107. Corona et al.108 found 
severe erectile dysfunction in 22.7% of 23 men with 
Klinefelter syndrome, HSDD in 60.9% of these men, and 
premature or delayed ejaculation in 9.5% of these men, 
using a validated structured interview. However, after 
adjusting for confounders, the authors concluded that 
sexual dysfunction in men with Klinefelter syndrome 
was not specifically associated with the syndrome but 
with the underlying hypogonadal state108, similar to the 
results of other studies109. El Bardisi et al.110 assessed sex-
ual dysfunction in 53 men with Klinefelter syndrome 
using the IIEF-5 and the Arabic index for premature 
ejaculation questionnaire. These investigators reported 
incidences of erectile dysfunction, premature ejacula-
tion, and HSDD of 18.9%, 22.6%, and 54.7%, respec-
tively. In addition, patients with Klinefelter syndrome 
had significantly lower libido and premature ejaculation 
frequency (P < 0.001 and P < 0.05, respectively) but sim-
ilar erectile function compared with 75 age-matched 
men without Klinefelter syndrome110. Another study 
reported no difference in the IIEF-5 score between 86 
men with nonmosaic Klinefelter syndrome and 80 men 
with mosaic Klinefelter syndrome111. The prevalence of 
sexual dysfunction in men diagnosed with a 46,XX kar-
yotype undergoing fertility evaluation has been reported 
to be 20%112. Finally, untreated men with isolated hypog-
onadotropic hypogonadism or Kallmann syndrome are 
infertile owing to aspermia or azoospermia and have 
reduced or absent sexual activity113.
No studies are available on sexual dysfunction in rela-
tion to obstructive azoospermia per se; however, infor-
mation on sexual dysfunction in men with obstructive 
azoospermia can be extrapolated from studies primar-
ily focused on patients with cystic fibrosis, as in 98% of 
instances they are infertile owing to obstructive azoo-
spermia because of complete or partial agenesis of the 
vas deferens114. In these men, sexual dysfunction and dif-
ficulty in establishing intimate relationships have been 
reported114. However, these concerns were more often 
associated with disease-related problems than obstruc-
tive azoospermia status114,115. In general, sexual func-
tion is not affected until cystic fibrosis becomes severe 
enough to interfere with the patient’s general health116,117. 
Adolescent and young adult men with cystic fibrosis are 
often aware that their infertility status does not affect 
sexual function114,117. However, approximately one in five 
men with cystic fibrosis reports that infertility affects his 
personal relationships116.
In conclusion, the discovery of azoospermia in an 
infertility setting is associated with erectile dysfunc-
tion15,19,58,59. Men with azoospermia also have a higher 
prevalence of other sexual dysfunctions (premature ejac-
ulation, HSSD, and orgasmic dysfunction) than fertile 
men15. Men with Klinefelter syndrome show high rates 
of sexual dysfunction108,110 associated with their hypo-
gonadal state108,109. They show similarerectile function 
to age-matched men without this syndrome, although 
they have a higher frequency of other sexual dysfunc-
tions110. However, men with Klinefelter syndrome have 
worsesexual function than fertile men106 but similar to 
infertile men without azoospermia in the infertility set-
ting107. Overall, these data suggest a negative role for the 
awareness of infertility status on sexual function of men 
with Klinefelter syndrome. Untreated men with congeni-
tal hypogonadotropic hypogonadism have infertility and 
reduced sexual activity113. Finally, men with obstructive 
azoospermia owing to cystic fibrosis can develop sexual 
dysfunction114 associated with the severity of the disease 
and disease-related problems114–117.
Psychological disorders
The association between couple infertility and psy-
chological burden has been widely recognized, lead-
ing the European Society of Human Reproduction and 
Embryology (ESHRE) to develop clinical practice guide-
lines118. These guidelines provide recommendations to 
improve the quality of psychosocial care for couples with 
infertility and during ART. The ESHRE guidelines118 
report that patients starting first-line treatments for 
infertility or ART do not have worse marital and sexual 
relationships than the general population (grade B recom-
mendation) and that patients receiving fertility treatment 
do not have higher prevalence rates of sexual dysfunction 
than the general population (grade C recommendation)118. 
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However, the ESHRE guidelines considered only one 
study66 focused on the relationship between infertility, 
psychological burden, and sexual dysfunction, comparing 
it with two studies performed in the general population8,12. 
Subsequent studies have reported an association between 
psychological burden and sexual dysfunction in infertile 
men17–19. Infertile men can develop feelings of inade-
quacy, guilt, depression, distress, anxiety, low virility, low 
self-esteem15,17–19,119, and psychological pressure resulting 
from sex aimed at conception20,98. Furthermore, infertility 
per se and related psychological problems can be asso-
ciated with sexual dusfunction15,17–19. To date, only five 
studies have systematically investigated the relationship 
between psychopathological disorders and sexual func-
tion in men in infertile couples (TABLE 1). Shindel et al.21 
observed a significant negative relationship between pre-
mature ejaculation and self-esteem and relationship qual-
ity in 73 males in infertile couples using an unvalidated 
survey to assess premature ejaculation and the SEAR 
scale (P = 0.02). Lotti et al.14 found a significant associ-
ation between erectile dysfunction, which was assessed 
using the IIEF-15-EFD score, and depressive symptoms 
(P < 0.05), which were evaluated using the validated 
psychometric tool Middlesex Hospital Questionnaire 
(MHQ), in 244 men with couple infertility. In the same 
study14, a significant association was found between the 
validated Premature Ejaculation Diagnostic Tool (PEDT) 
score and phobic anxiety (P < 0.01), which was evaluated 
using the MHQ. Gao et al.16 found that IIEF-5 score was 
negatively associated with anxiety, which was evaluated 
using the self-rating anxiety scale (SAS), and depression, 
which was assessed using the self-rating depression scale 
(SDS) (both P < 0.001), whereas the PEDT score was 
positively associated with anxiety and depression (both 
P < 0.001) in a cohort of 1,498 infertile men. In addition, 
these investigators also reported a negative association 
between the intravaginal latency time, which was assessed 
using a stopwatch method, and anxiety and depression 
(both P < 0.001). Song et al.20 observed a negative corre-
lation between IIEF-5 score and stress level during timed 
intercourse, which was evaluated using a visual analogue 
scale. Finally, Lotti et al.15 found that erectile dysfunction 
prevalence increased as a function of severity of semen 
quality impairment, independently of physical, hormo-
nal, glycometabolic, or penile vascular parameters in men 
in fertile or infertile couples. Using a moderator analysis, 
these researchers15 observed that, in infertile men, erec-
tile dysfunction was associated with mood disturbances, 
particularly with somatized anxiety, and that the negative 
relationship between erectile function, which was eval-
uated with the IIEF-15-EFD score, and somatized anxi-
ety, which was evaluated with the MHQ, was stronger in 
men with azoospermia (F = 25.5, P < 0.0001) than in other 
categories of infertile men. In addition, men with azoo-
spermia had higher rates of premature ejaculation (which 
was related to overall psychopathological symptoms) and 
lower sexual desire and orgasmic function (which were 
related to depressive and somatized anxiety symptoms) 
than fertile men15.
In summary, in males in infertile couples, erectile 
dysfunction and premature ejaculation are associated 
with psychological disorders, including anxiety, depres-
sion, and distress. The prevalence of erectile dysfunc-
tion increases as a function of severity of semen quality 
impairment, and is higher in men with azoospermia 
than in other men in an infertile or fertile couple15. 
Hence, investigation of sexual function and psycholog-
ical status of men in infertile couples, especially if azoo-
spermia is present, is advisable, to improve reproductive 
and sexual health.
Male infertility and general health
A proxy of general health
Male sexual dysfunction is a well-known index of 
decreased general health22,120. Several conditions, such 
as cardiovascular, glycometabolic, neurological or endo-
crine disorders, and cancer, as well as their treatments, 
such as medication, surgery, chemotherapy, and radio-
therapy, might all cause organic erectile dysfunction22. 
Currently, erectile dysfunction is considered an indica-
tor of underlying cardiovascular and metabolic disorders 
and as a reliable proxy of general health status120–122. In 
addition, premature ejaculation could be secondary to 
organic causes, such as prostatic inflammation or hyper-
thyroidism123. Furthermore, HSDD, delayed ejaculation, 
and orgasmic impairment might be caused by neuro-
logical and endocrine diseases, or by iatrogenic causes, 
including psychotropic drugs124,125.
Male infertility has also been associated with 
decreased general health status15,23,24,126–129. In fact, men in 
an infertile couple have a higher rate of malignant126–129 
and nonmalignant15,24 diseases than age-matched men 
without couple infertility. Accordingly, increased rates 
of semen abnormalities are associated with decreased 
general health25,130 and increased mortality131,132 in 
infertile men. Furthermore, childless men (including 
men with couple infertility, but also men who may 
have decided not to procreate) have a higher risk of 
dying from cardiovascular disease than men who are 
fathers133. Interestingly, subfertile males often have tes-
tosterone deficiency33,134, which is associated with seri-
ous life-threatening conditions such as atherosclerosis, 
metabolic syndrome, and diabetes134–137. Male infertility 
shares particular genes and/or molecular pathways with 
other pathologies (such as urological and fibrous tissue 
neoplasms, lymphoma, myositis and dermatomyositis, 
and frontotemporal lobar degeneration) and has distinct 
clinical relationships with other diseases (including tes-
ticular and high-grade prostate cancer)138.
Lotti et al.15 observed that men with azoospermia 
had the highest frequency of erectile dysfunction and 
the worst health status in an evaluation of men in infer-
tile and fertile couples (TABLE 1). Furthermore, erectile 
dysfunction was associated with decreased health sta-
tus only in men with azoospermia. The investigators 
suggested that the presence of erectile dysfunction 
in infertile men, particularly men with azoospermia, 
might prompt physicians to evaluate possible subclin-
ical underlying morbidities. An early diagnosis of erec-
tile dysfunction and the identification of its risk factors 
can provide useful information for eventually stratifying 
cardiovascular risk26,27,121,139,140. Whether or not erectile 
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dysfunction in infertile men might be an earlier marker 
of cardiovascular diseases needs further investigation. 
A 2017 study reported an association between failure 
in fertility therapy and an increased risk of long-term 
adverse cardiovascular events in women141; however, 
such studies are lacking in infertile men. Together, these 
observations show that the concept that erectile dysfunc-
tion in infertile men might be an early marker of poor 
general health is emerging.
General health disorders
The aetiologies of impaired sperm production, func-
tion, or release can be related to different congenital 
or acquired conditions that act at a pretesticular level 
(such as congenital or acquired hypogonadotropic hypo-
gonadism and sexual dysfunction), a post-testicular 
level (such as congenital bilateral absence of vas defer-
ens, ejaculatory duct obstruction caused by a congenital 
midline prostate cyst or acquired after prostate infection 
or inflammation, vasectomy, and antisperm antibodies), 
or directly at the testicular (such as congenital anorchia, 
karyotype abnormalities, and Y chromosome deletions 
and acquired causes such as orchitis, testicular torsion, 
trauma, irradiation, and chemotherapy) level14,28,34–36. 
Among these disorders, systemic diseases (such as 
chronic renal or liver failure, and respiratory, neuro-
logical, and endocrine diseases) have been reported 
as individual disorders in 2.2% of a large cohort of 
patients attending the Münster Institute of Reproductive 
Medicine34 and in 0.5% of a subgroup of 1,446 men with 
azoospermia. A 2017 study35 indicates that chronic dis-
eases (including cardiovascular, renal, gastrointestinal, 
joint, neurological and endocrine diseases, asthma, and 
depression) contributed to severe male factor infertility 
in 24.4% of 1,737 men, showing a significantly higher 
prevalence than in 325 fertile men (9.8%) (P < 0.001).
Systemic diseases can affect semen parameters23 
and male sexual function22, as they often share com-
mon pathological mechanisms (TABLE  2). Systemic 
diseases can cause disruption of the hypothalamic–
pituitary–gonadal (HPG) axis23, leading to testosterone 
deficiency23,33, which, in turn, can eventually result in 
erectile dysfunction, HSDD, and delayed ejaculation85,142. 
The mechanism related to defective HPG axis regulation 
is called ontogenic regression and refers to the orderly 
regression of reproductive function in a fashion that 
permits facile recrudescence when a more favourable 
environment prevails23. Along with disruption of the 
HPG axis, other common features of systemic illness, 
such as increased cytokine levels, fever, weight loss, and 
increased catabolism can all reduce testicular function23.
The negative reproductive and sexual effects of non-
testicular illnesses depend on age as well as how severe 
and chronic the underlying disease is23,143,144. Acute and 
chronic illnesses are often associated with suppression of 
gonadotropin secretion and secondary hypogonadism, 
but primary hypogonadism can also occur23,144. Notably, 
about 20% of all children have a chronic illness that 
often leads to growth failure and delay or absence of 
sexual development during puberty and to subfertility 
and sexual dysfunction during adolescence and early 
adulthood143. This observation is relevant because many 
studies indicate that adolescents and young adults are 
sexually active and interested in knowing about their 
future fertility143. Furthermore, reproductive and sexual 
impairment can affect the future quality of life of these 
patients and are predictors of stress in current and future 
relationships143.
Thus, causes of semen abnormalities and sexual dys-
function are multifactorial and can be caused by the dis-
ease itself and its associated complications143. Adequate 
information must be provided to patients about repro-
ductive and sexual health, and transitional care between 
paediatric and adult medical care should be improved143.
Medical treatments
Male infertility treatments
Male infertility treatments include therapeutic strategies 
aimed at treating both correctable and idiopathic causes 
of infertility. Correctable causes of infertility include 
hypogonadotropic hypogonadism and other endocrine 
disorders, varicocele, and sexual problems (erectile dys-
function and other ejaculatory disorders).
Hypogonadotropic hypogonadism. Treatment of hypo-
gonadotropic hypogonadism in infertile men includes 
selective oestrogen receptor modulators, gonadotropins 
and, less frequently, aromatase inhibitors, which can 
restore serum testosterone levels, providing sympto-
matic relief without affecting sperm production145–147. 
Conversely, exogenous testosterone, a medication 
known for its contraceptive potential, should not be used 
for male infertility treatment145–147. Several studies have 
evaluated the effect of the aforementioned medications 
on testosterone levels in hypogonadal men of repro-
ductive age145–147, but only a few evaluated their effect 
on sexual function148,149, and no study had evaluated 
this issue in infertile men. Guay et al.148 demonstrated 
that treatment with clomiphene citrate for 4 months in 
173 men with secondary hypogonadism and erectile 
dysfunction was associated with an improvement in 
sexual function in 75% of men, probably by increasing 
luteinizing hormone and free testosterone levels. Similar 
results were observed in a smaller cohort (n = 17), in a 
subgroup of eight men with a mean age of 53 years who 
were younger than the rest of the sample (n = 9, mean age 
66.4 years), and in those with fewer medical risk factors, 
including diabetes and hypertension (n = 8)149. Responses 
to treatment significantly decreased as a function of age 
(P < 0.05), concomitant diseases (hypertension and 
coronary artery disease; both P < 0.05), or use of mul-
tiple medications (P < 0.05)148. Similarly, other studies 
reported a significant improvement in the Androgen 
Deficiency in Ageing Male sexual function domain score 
in hypogonadal men receiving clomiphene citrate treat-
ment (all P < 0.05)150–152. Finally, a placebo-controlled 
study performed in a small cohort (n = 45) of men with 
nonorganic erectile dysfunction or HSDD with normal 
(>4 ng/ml) or slightly decreased (2–4 ng/ml) testoster-
one levels indicated that human chorionic gonadotropin 
(hCG) treatment was associated with an improvement in 
sexual behaviour in ~50% of the cases153.
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Table 2 | Systemic diseases that might lead to semen abnormalities and sexual dysfunction
Systemic diseases Semen abnormalities and sexual dysfunctions and possible underlying mechanisms
Renal diseases
Chronic renal failure • Frequent testosterone deficiency owing to hypogonadotropic hypogonadism and testicular damage
• Inhibition of HPG axis: hypogonadotropic hypogonadism, with gonadotropin levels inappropriately low for the low 
testosterone levels; however, masked by reduced clearance related to uraemia, which can lead to apparently high 
gonadotropin levels23
• Luteinizing hormone insensitivity of Leydig cells23
• Increased testosterone clearance23
• Impaired spermatogenesis, including azoospermia, and low semen volume177
• Possible cytotoxic effect of uraemia on spermatogonia23
• High rates of sexual dysfunction (mainly erectile dysfunction and HSDD) related to testosterone deficiency, uraemia, 
fatigue, and psychosocial factors22,178
Dialysis and renal 
transplantation
• Dialysis is associated with testosterone deficiency23, sperm abnormalities177, and sexual dysfunction178; however, better 
than end-stage renal disease177
• Renal transplantation restores testicular function, spermatogenesis177, and erectile function22
Liver diseases
Chronic liver failure • Increase in SHBG levels and decrease of bioavailable testosterone; gonadotropin in the low-to-normal range; 
additional direct testicular damage from alcohol in alcohol-related forms of the disease23
• Impaired HPG axis and hypogonadotropic hypogonadism in cirrhosis and increased peripheral conversion of 
androgens to oestrogens179
• Sperm abnormalities, including azoospermia23; antisperm antibodies in alcohol-related forms of the disease180
• Erectile dysfunction181 and HSDD181
Liver transplantation • Improvement in testosterone levels, erectile function181, and sperm parameters23 with respect to end-stage liver 
disease; however, mild-to-moderate sexual dysfunction might persist182




• Iron deposition in liver and pancreas can lead to cirrhosis and diabetes, respectively23, with further negative effects on 
sexual and reproductive health
Respiratory diseases
Cystic fibrosis • 98% of men with cystic fibrosis have congenital bilateral absence of vas deferens and obstructive azoospermia114
• Men with cystic fibrosis can develop sexual dysfunction114 related to the severity of the disease and related 
problems114–117
Sarcoidosis • 50% of men with sarcoidosis show hypogonadotropic hypogonadism23
• Neural involvement in 5% of men with sarcoidosis (neurosarcoidosis) can produce hypogonadotropic hypogonadism by 
pituitary infiltration23




• Testosterone deficiency owing to primary illness and glucocorticoid therapy185
• Supposed effect on male reproductive function, but debated23
• Erectile dysfunction22
Genetic neurological disorders
Myotonic dystrophy • Compensated or hypergonadotropic hypogonadism186
• Sperm abnormalities, including azoospermia187
• 25% of men with myotonic dystrophy have erectile dysfunction186
Kennedy disease • Testosterone deficiency188
• Sperm abnormalities188,189 and sexual dysfunction189
Acquired neurological disorders
Multiple sclerosis • 25% of men with multiple sclerosis have testosterone deficiency23
• Spermatogenesis impaired according to authors46, not impaired for other authors23, but infertility might occur when 
erectile dysfunction and/or ejaculatory disorders are present23
• Sexual dysfunction, including erectile dysfunction, HSDD, ejaculatory disorders, and orgasmic dysfunction22
Polyneuropathy • Erectile dysfunction and ejaculatory disorders22 can lead to infertility
Spinal cord injury • Spinal cord injury is the most common cause of neurogenic anejaculation45.
• Only 9% of men with spinal cord injury can achieve ejaculation via masturbation or sexual intercourse46
• 50–75% of men with spinal cord injury have erectile dysfunction190
Epilepsy • Testosterone deficiency, erectile dysfunction, and HSDD22
• Semen parameters mildly affected191
Head injury • Partial or complete pituitary dysfunction, including hypogonadotropic hypogonadism23, leading to sperm abnormalities 
and sexual dysfunction
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Table 2 (cont.) | Systemic diseases that might lead to semen abnormalities and sexual dysfunction
Systemic diseases Semen abnormalities and sexual dysfunctions and possible underlying mechanisms
Acquired neurological disorders (cont.)
Pituitary adenoma • Hypogonadotropic hypogonadism for macroadenoma affecting gonadotropins by pituitary compression against sella 
turcica, or possible hormonal hypersecretion (prolactin, ACTH, and growth hormone) owing to pituitary adenoma 
finally affecting the HPG axis192, leading to sperm abnormalities and sexual dysfunction
Gastrointestinal diseases





• Testosterone deficiency, debated23
• Impaired spermatogenesis196; increased levels of antisperm antibodies197
• Sexual dysfunction195
Haematological diseases
β-Thalassemia • Hypogonadotropic hypogonadism and impaired spermatogenesis198
• Erectile dysfunction199
Sickle cell disease • Testosterone deficiency, sperm abnormalities, and erectile dysfunction, also related to complicated priapism200
Endocrine and metabolic diseases
Hyperprolactinaemia • HPG axis suppression and hypogonadotropic hypogonadism; sexual dysfunction, including erectile dysfunction and 
HSDD, owing to secondary testosterone deficiency and direct negative effect of prolactin levels on sexual desire85
• Semen abnormalities201
Hyperthyroidism • Increased SHBG and decreased bioavailable testosterone levels87
• Sperm abnormalities86,87
• Erectile dysfunction and premature ejaculation85
Hypothyroidism • Decreased SHBG and testosterone levels87
• Semen abnormalities86,87
• Erectile dysfunction and delayed ejaculation85
Hypercortisolism • Inhibition of HPG axis and hypogonadotropic hypogonadism; possible effect on reproductive and sexual function202
Acromegaly • Hypogonadotropic hypogonadism and sperm abnormalities (also caused by an excess of growth hormone)203,204
• Erectile dysfunction, mainly organic204
Congenital adrenal 
hyperplasia
• Sperm abnormalities owing to hypogonadotropic hypogonadism, testicular failure, and testicular adrenal rest 
tumours205
• Sexual dysfunction206
Diabetes mellitus • Hypogonadotropic hypogonadism207
• Semen abnormalities and ejaculatory disorders, including retrograde ejaculation43
• Erectile dysfunction22
Obesity • Hypogonadotropic hypogonadism208
• Reduced reproductive potential209, but sperm abnormalities are debated210,211
• Erectile dysfunction22
Metabolic syndrome • Hypogonadism owing to central and testicular function impairment212
• Men with metabolic syndrome show lower values of normal sperm morphology than those without122. In men with 
primary couple infertility, no difference in semen parameters have been reported when comparing men with and 
without metabolic syndrome136. In men with secondary couple infertility, patients with metabolic syndrome showed 





• Sexual dysfunction owing to disease-related symptoms (pain, fatigue, functional impairment, and psychological 
disturbances), hypogonadism, and impaired fertility owing to increased levels of antisperm antibodies and testosterone 
deficiency in rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis213
Infectious diseases
HIV • Testosterone deficiency214
• Semen abnormalities215
• Erectile dysfunction in 30–50% of men with HIV216
Sexually transmitted 
infections
• Possible negative effect on semen parameters; however, this issue and effects on fertility are debated200
• Erectile dysfunction and premature ejaculation in urogenital infections217
Human papilloma virus • Some evidence for HPV as a risk factor for fertility, with possible negative effects on semen quality, IVF failure, and 
miscarriages, but its influence is debated, as is the role of HPV clearance in restoring fertility218
• Risk factors for HPV infection in both sexes are number of lifetime partners and young age219,220
• Women with vulvar lesions more often worry about sexual consequences (such as being unable to have children, being 
sexually less attractive, or infecting a sexual partner) than those without221.
• Men with genital warts have higher rates of sexual dysfunction, depression, and anxiety than the general population222
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Other endocrine and metabolic disorders. Other endo-
crine and metabolic disorders potentially related to 
abnormal semen parameters and sexual dysfunction 
include hyperprolactinaemia, hyperthyroidism and 
hypothyroidism, congenital adrenal hyperplasia, acro-
megaly, hypercortisolism, diabetes mellitus, metabolic 
syndrome, and obesity (TABLE 2). Treatment of these dis-
orders can result in normalization of semen parameters 
and sexual function85,86,154.
Varicocele. Varicocele is considered as an aetiological 
factor in male infertility28,35,155. Varicocele is often asso-
ciated with a reduction in serum testosterone levels, 
and varicocelectomy can reverse some of the adverse 
effects of androgen deficiency, including sexual dys-
function156,157. A few studies have found an association 
between varicocele and sexual dysfunction. One study 
reported an association between varicocele and pre-
mature ejaculation, likely owing to varicocele-related 
congestion of the periprostatic venous plexus and pros-
tate inflammation158. Varicocelectomy has been associ-
ated with improvement in premature ejaculation159,160. 
However, further prospective studies with larger 
patient groups are needed to confirm this finding161. 
Furthermore, in a large population-based case-con-
trol study, a higher prevalence of varicocele has been 
observed in participants with erectile dysfunction than 
those without162. Varicocelectomy has been associated 
with an improvement in IIEF-5 score in infertile men 
with hypogonadism (baseline total testosterone levels 
<300 ng/dl), probably related to an increase in testos-
terone levels after surgery163. Finally, 34 − 67% of men 
with varicocele and infertility reported HSDD158,163, 
and HSSD was attributed to a varicocele-induced 
decline in testosterone levels163. However, the possibil-
ity that infertility per se causes HSDD should also be 
considered156.
Idiopathic male infertility. Regarding idiopathic male 
infertility, a survey of practising American Urological 
Association members164 evaluating treatments used by 
347 urologists found that 60.5% would treat infertile 
men with empirical therapy for 3–6 months, mainly 
using clomiphene citrate and hCG, but also testoster-
one (25%), which can have deleterious effects on sperm 
production. Comparing fellowship-trained and general 
urologists, the latter group showed a significantly higher 
use of testosterone (P = 0.001) and a lower use of hCG or 
anastrazole (both P < 0.001)164. These findings highlight 
the need to establish recommendations on the empirical 
use of medical therapy in the setting of male infertility164, 
and to transfer this knowledge, especially to the general 
urologists.
Assisted reproductive technologies. ARTs can lead to 
sexual dysfunction19,165. ARTs are the infertility treat-
ments of choice for couples unable to obtain natural 
pregnancy166. A 2014 survey by the Italian Society of 
Andrology and Sexual Medicine167 demonstrated that 
men undergoing ART often have erectile dysfunction 
Table 2 (cont.) | Systemic diseases that might lead to semen abnormalities and sexual dysfunction
Systemic diseases Semen abnormalities and sexual dysfunctions and possible underlying mechanisms
Infectious diseases (cont.)
Male accessory gland 
infection
• Possible negative effect on semen parameters223; effect on fertility debated215
• Sexual dysfunction (erectile dysfunction, premature ejaculation, or HSDD) in up to 50% of men224
Mumps • 15–30% of adult men develop epididymo-orchitis, with sperm abnormalities in up to 25% of patients, and normal or 
decreased testosterone levels225, which might lead to sexual dysfunction226
Lepromatous leprosy • Possible testicular and epididymal abnormalities, with sperm abnormalities227
• Sexual dysfunction in up to 60% of men227












Psoriasis • Impaired spermatogenesis231
• Erectile dysfunction232
Amyloidosis • Hypogonadism owing to testicular amyloid deposition233
• Semen abnormalities233
• Erectile dysfunction in amyloid neuropathy234
Behçet disease • Genitourinary inflammation and recurrent fever affect spermatogenesis235
• Sexual dysfunction236
ACTH; adrenocorticotropic hormone; HPG, hypothalamus–pituitary–gonadal; HPV, human papilloma virus; HSDD, hypoactive sexual desire disorder; IVF, in vitro 
fertilization; SHBG, sex-hormone-binding globulin.
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(56.2%), premature ejaculation (25%), or HSDD 
(18.7%). The reasons for the development of sexual 
dysfunction in this setting include partner, couple and 
clinical team expectation of ART success, leading to 
anxiety and distress, the sex for the reproduction pro-
cess itself, and the need to provide one or more semen 
samples on demand using masturbation17–19,165. Long 
periods of diagnostic and treatment procedures can 
have a detrimental role in sexual life168. However, only 
a few studies have evaluated the relative effect of the 
duration of infertility, of the related work-up, and of 
treatment on male sexual function and marital rela-
tionship65,88,95,169 but not with these factors as a primary 
end point and without definitive results. One study 
reported that a 3-month treatment with clomiphene cit-
rate of female partners of men with primary infertility 
performed before intrauterine insemination was asso-
ciated with an increase of sexual dysfunction frequency 
in both members of the couple169. In particular, men 
showed reduced sexual drive, arousal, orgasm inten-
sity, and satisfaction compared with those observed 
before treatment, as assessed with the Arizona Sexual 
Experience Scale169. Another study88 reported that, 
when comparing infertile men diagnosed and treated 
recently (within 3 months) to those managed for a 
longer period (3–180 months), those men treated for 
longer had reduced sexual satisfaction; however, sexual 
satisfaction was not different from that recalled before 
diagnosis. The size of the recently diagnosed group was 
too small (n = 12) to draw conclusions, and larger stud-
ies are advisable88. Another study found no association 
between duration of infertility and IIEF-15 subdomain 
score65, whereas another found a higher rate of marital 
conflicts in couples with a duration of 3–6 years of infer-
tility problems than those with a longer or shorter dura-
tion95. Thus, further research on this topic is warranted. 
Finally, masturbation is considered as an immoral prac-
tice in some cultures and religions, and is perceived with 
guilt by some patients undergoing ART, possibly leading 
to psychogenic erectile dysfunction or anejaculation19.
In summary, the treatment of correctable causes of 
infertility in men with sexual dysfunction can lead to 
improvement of both semen parameters and of sex-
ual function. In particular, the treatment of men with 
hypogonadotropic hypogonadism and sexual dys-
function with clomiphene citrate is associated with an 
improvement in sexual function148–152, probably owing 
to an increase in testosterone levels148. These results 
are from studies performed in men without infertil-
ity, but they can be extended to an infertility setting. 
In fact, clomiphene citrate, as well as hCG, are often 
used as empirical therapies for idiopathic male infer-
tility164. However, testosterone is also frequently used 
(wrongly) in the infertility setting, although it should 
be avoided in men seeking pregnancy because of its 
contraceptive potential164. Treatment of some endo-
crine and metabolic disorders in men with semen 
abnormalities can result in an improvement of semen 
parameters and sexual function85,86,154. One study163 
reported that varicocelectomy is associated with an 
improvement in erectile function in infertile men 
with hypogonadism. Evaluation and assisted treatment 
(ART) of infertility is an important risk factor for sex-
ual dyfunction165,167,168.
Medication and infertility
Increasingly, young men (aged <40–45 years) require 
long-term medication (such as chemotherapy for 
tumours, psychotropic agents for psychological or psy-
chiatric disorders, and testosterone replacement therapy 
for hypogonadism secondary to obesity, diabetes, or meta-
bolic syndrome), of which the effects on reproduction and 
sexuality are often inadequately considered170. Medication 
can affect male reproduction through central suppression 
of the HPG axis, direct gonadotoxic effects, reducing 
semen quality, or inducing sexual dysfunction33,170. In par-
ticular, sexual dysfunction has commonly been reported 
as an adverse effect of many drugs (such as psychotropic 
agents for psychological or psychiatric disorders, some 
antihypertensive medications for hypertension, 5α-reduc-
tase inhibitors for male pattern baldness and benign pros-
tatic hyperplasia, and α-blockers for lower urinary tract 
symptoms or benign prostatic hyperplasia)171,172. Many 
medications have reversible effects on male fertility, but 
some of them, such as chemotherapeutic agents, can lead 
to irreversible infertility and, eventually, decreased testos-
terone production (TABLE 3). Men should be counselled 
appropriately about potential drug-related adverse effects 
on their fertility and sexual function.
Sexual dysfunction in couple infertility
Sexual dysfunction in men in an infertile couple can 
be the cause or the consequence of the infertility sta-
tus or might be present independently. When sexual 
dysfunction is independent of the infertility status, the 
cause must be investigated, and treatment must be per-
formed according to available guidelines of the EAU173 
and of the International Society of Sexual Medicine174,175, 
avoiding use of those medications affecting fertility if 
possible (TABLE 3). When the possible underlying cause 
of both sexual dysfunction and infertility is recognized, 
such as a systemic disorder (BOX 1; TABLE 2) or ongoing 
medication (TABLE 3), the condition must be treated or 
the medication discontinued or changed to a suitable 
alternative. Patients should be monitored in order to 
evaluate any possible improvement. Of note, several 
systemic disorders are associated with hypogonadism 
(TABLE 2). If hypogonadism is present in a man seeking 
infertility treatment, testosterone replacement therapy 
(TRT) must be avoided and other medications consid-
ered (such as hCG, selective oestrogen receptor modula-
tors, or aromatase inhibitors), as TRT can further reduce 
semen quality145–147. Anejaculation can be treated with 
psychotherapy or medication when caused by a psycho-
genic or marital issue174,176. However, when anejaculation 
is resistant to treatment or not correctable (such as when 
it is secondary to severe organic or iatrogenic causes; 
BOX 1), only fertility can be treated by performing TESE 
and ART. Regarding HSDD, orgasmic dysfunction, and 
satisfaction impairment, medical and/or psychological 
therapy can be performed174–176, possibly avoiding med-
ications that would worsen subfertility.
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Table 3 | Commonly used medications and semen abnormalities and sexual dysfunction
Commonly used 
medications
Semen abnormalities Mechanisms leading to 
semen abnormalitiesa





Suppression of the HPG axis Amelioration of sexual 
function142
Central and peripheral effect
BPH treatments
α-Blockers • Retrograde ejaculation237
• Decreased semen 
volume237
• Reduced sperm count 
and motility237
• Inhibition of bladder neck α1A 
receptors
• Inhibition of vas deferens 
and epididymal α1A receptors 
and reduced contractility






• Decreased sperm count 
in 5% of men239





• Erectile dysfunction up 
to 15% of men240






NA NA NA Serotoninergic, anticholinergic, 
α-blocker, and/or antidopaminergic 
properties
SSRIs • Increased sperm DNA 
fragmentation241
• Direct spermicidal effect 
(in vitro)241
• Decreased sperm 
motility241
• Oxidative phosphorylation 
of sperm mitochondria or 
effect on the sperm cell 
membrane
• Hyperprolactinaemia with 
suppression of the HPG axis
• Erectile dysfunction 
(up to 60% of men)242
• Delayed or absent 
ejaculation (variable 
degree)242
• Hyperprolactinaemia, with 
suppression of the HPG axis
• Impaired binding of luteinizing 




• Decreased sperm 
motility243
• Decreased semen 
volume243
Hyperprolactinaemia with 
suppression of the HPG axis
Erectile dysfunction 
and delayed or 
absent ejaculation 
(variable degree) with 
phenothiazines242
Hyperprolactinaemia with 
suppression of the HPG axis
MAO inhibitors Azoospermia with 
anejaculation244
Blocks the enzyme MAO, 
which normally inactivates 





Blocks the enzyme MAO, 
which normally inactivates the 
monoamines serotonin, dopamine, 
and noradrenaline




Decrease in central nervous system 
dopamine levels
Antihypertensive medications




Central (amygdala and cerebral 
cortex) and penile (sympatholytic 
effect) β1-adrenergic receptor 
inhibition
Diuretics Decreased sperm 
concentration and motility 
(spironolactone)247




• Antiandrogenic effect 
(spironolactone)










• One report of sperm 
motility decrease with 
acute tadalafil use249
Phosphodiesterases are 
expressed in human sperm, 
Leydig cells, and several 




Phosphodiesterases expressed in 
several organs; phosphodiesterase 
type 5 in the penis is the target of 




• Azoospermia or 
reduction in conventional 
sperm parameters170
• Sperm DNA 
fragmentation170
• Sperm aneuploidy for up 
to 2 years170
• Gonadotoxicity from 
damage to Sertoli or Leydig 
cells and spermatogonial 
stem cells; risk of genetically 
abnormal sperm precursors
• Alkylating agents produce 
covalent bonds between DNA 
strands and block cell division
• HSDD230
• Erectile dysfunction230
Decrease in testosterone 
production by damage to Leydig 
cells; fatigue, pain, or anxiety about 
therapy
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Conclusions
Sexual dysfunction is a rare cause of male infertility; 
however, every type of sexual dysfunction has been 
observed in infertile men. In fact, one out of six men in 
an infertile couple has erectile dysfunction or premature 
ejaculation, whereas orgasmic dysfunction is estimated 
to be present in one out of ten infertile men. HSDD and 
lack of satisfaction in sexual life are the most prevalent 
types of sexual dysfunction in infertile men. The infer-
tility status and its related psychological concerns can 
underlie sexual dysfunction.
General health perturbations can lead to male infer-
tility and/or sexual dysfunction. Indeed, erectile dys-
function and male infertility are considered proxies of 
general health. Furthermore, the concept that erectile 
dysfunction in infertile men might be an early marker 
of poor general health is emerging. Men with azoo-
spermia show the highest rates of psychological and 
general health disturbances, which are associated with 
an increased prevalence of sexual dysfunction. Finally, 
commonly used medications for general health problems 
can lead to sperm abnormalities and sexual dysfunction, 
and, therefore, adequate information must be provided 
to patients. Preliminary evidence indicates that the treat-
ment of some correctable causes of male infertility can 
improve semen quality and reverse infertility-related sex-
ual dysfunction. Investigation of sexual function, general 
health, and psychological status of men in an infertile 
couple, especially if they have azoospermia, is advisable, 
to improve reproductive, general, and sexual health.
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Table 3 (cont.) | Commonly used medications and semen abnormalities and sexual dysfunction
Commonly used 
medications
Semen abnormalities Mechanisms leading to 
semen abnormalitiesa
Sexual dysfunctions Mechanisms leading to sexual 
dysfunctionsa
Immunosuppressive drugs
Sulfasalazine Reduction in 
conventional sperm 
parameters, induction of 
azoospermia250
Negative effect on 
spermatozoa of the 
sulfapyridine metabolite of 
sulfasalazine250
Rare reports of erectile 
dysfunction251
Unknown
Methotrexate Reduction in 
conventional sperm 












Reduction in conventional 
sperm parameters252
Increase of SHBG and 




Increase of SHBG and reduction of 
bioavailable testosterone levels
DHT, dihydrotestosterone; HPG, hypothalamus–pituitary–gonadal; HSDD, hypoactive sexual desire disorder; MAO, monoamine oxidase; NA, not applicable; SHBG, 
sex-hormone-binding globulin; SSRI, selective serotonin reuptake inhibitor. aSee REFS 170,213,251,252.
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In this Review, Lotti and Maggi discuss the correlations 
between sexual dysfunction and male infertility, focusing 
on the associations between reproductive, sexual, 
psychological, and general health.
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